AI
SPONSORED
HIMSS22 Europe
|
03:21 pm |
June 09, 2022
|
03:21 pm |
June 09, 2022
Shawn LaRocco, VP, global head of business, Customer Solutions at Olympus, explains that the future of AI solutions can improve clinical outcomes, patient safety and operational efficiencies.
The company is also close to getting its patent for the Us2.v1 software recognised in the US.
They will provide the first access to an AI-enabled minimal residual disease test in India.
Also: Drug discovery platform Insilico Medicine raises $60 million, Women's virtual care startup Visana Health brings in $2.6 million and digital reproductive care clinic Choix scoops up $1 million.
Two variants of the Annalise CXR Edge products will be offered in Australia.
The AI solution has been trained based on a data set of 3.2 billion patient visits.
Also, Standigm has partnered with Merck Korea for AI drug discovery research.
The AI platform can predict a person's risk of having a stroke or a heart attack in the next five years.
The chief digital and information officer offers a perspective on using ambient voice technology across departments to ease clinician burden and documentation.
It is coming up with its own database of skin and hair profiles and prescriptions.